Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,435 | -5,470 | -3,561 | -965 | 2,090 |
| Depreciation Amortization | 585 | 440 | 291 | 144 | 30 |
| Other Working Capital | -303 | -391 | -219 | 438 | -2,970 |
| Other Operating Activity | 1,184 | 987 | 586 | 58 | -6,950 |
| Operating Cash Flow | $-5,970 | $-4,435 | $-2,903 | $-325 | $-7,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -118 | -112 | -23 | N/A | N/A |
| Net Acquisitions | 906 | 906 | 906 | N/A | 0 |
| Other Investing Activity | 500 | 500 | 500 | 0 | 0 |
| Investing Cash Flow | $1,287 | $1,294 | $1,383 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,171 |
| Debt Repayment | -678 | -677 | -677 | -51 | -193 |
| Common Stock Issued | 10,165 | 4,866 | 4,866 | N/A | N/A |
| Other Financing Activity | 28 | -131 | -29 | 0 | -1,578 |
| Financing Cash Flow | $9,515 | $4,058 | $4,160 | $-51 | $1,400 |
| Beginning Cash Position | 674 | 674 | 674 | 674 | 8,760 |
| End Cash Position | 5,506 | 1,591 | 3,313 | 299 | 2,370 |
| Net Cash Flow | $4,832 | $917 | $2,640 | $-375 | $-6,390 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,970 | -4,435 | -2,903 | -325 | -7,800 |
| Capital Expenditure | -118 | -112 | -23 | N/A | -2 |
| Free Cash Flow | -6,089 | -4,547 | -2,926 | -325 | -7,802 |